| Literature DB >> 29431291 |
Rachel Khoo1, Shirley Jansen2,3,4,5.
Abstract
The diabetic heel ulcer (DHU) represents a reconstructive challenge to clinicians and the multidisciplinary team alike. It is traditionally viewed as a condition that is inherently difficult to treat due to the intrinsic anatomical vulnerabilities of the heel. In addition to this, several factors are associated with poorer end outcomes - namely, that of major amputation. These include peripheral vascular disease, infection/osteomyelitis and the size of the ulcer itself. In light of the significant morbidity, economic burden and mortality seen in this cohort of patients, this review aims to explore current treatment modalities that have been undertaken. Literature in this field has mostly been confined to a handful of small case studies, some of which reflect novel, multimodal approaches, and promising results. Management with osteotomy, flap reconstruction and acellular dermal matrices, amongst other options, is covered within this review.Entities:
Keywords: Acellular dermal matrix; Amputation; Diabetic heel ulcer; Flaps; Osteotomy
Mesh:
Year: 2018 PMID: 29431291 PMCID: PMC7949754 DOI: 10.1111/iwj.12839
Source DB: PubMed Journal: Int Wound J ISSN: 1742-4801 Impact factor: 3.315